131 related articles for article (PubMed ID: 20140540)
1. Acute promyelocytic leukemia in a young patient with breast cancer.
Kara O; Ozdemir E; Arslan C; Dogan E; Altundag K
Med Oncol; 2011 Mar; 28(1):249-50. PubMed ID: 20140540
[No Abstract] [Full Text] [Related]
2. Therapy-related acute promyelocytic leukemia caused by hormonal therapy and radiation in a patient with recurrent breast cancer.
Ono M; Watanabe T; Shimizu C; Hiramoto N; Goto Y; Yonemori K; Kouno T; Ando M; Tamura K; Katsumata N; Fujiwara Y
Jpn J Clin Oncol; 2008 Aug; 38(8):567-70. PubMed ID: 18617535
[TBL] [Abstract][Full Text] [Related]
3. BRCA2-associated therapy-related acute myeloid leukemia.
Rashidi A; Amarillo I; Fisher SI
Med Oncol; 2015 Jan; 32(1):371. PubMed ID: 25428384
[No Abstract] [Full Text] [Related]
4. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ;
Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269
[TBL] [Abstract][Full Text] [Related]
5. Secondary acute promyelocytic leukemia: an increasingly common entity.
Jantunen E; Heinonen K; Mahlamäki E; Penttilä K; Kuittinen T; Lehtonen P; Pyörälä M; Hänninen A; Nousiainen T
Leuk Lymphoma; 2007 Jan; 48(1):190-1. PubMed ID: 17325866
[No Abstract] [Full Text] [Related]
6. Secondary leukemia after autologous peripheral blood progenitor cell transplantation for breast cancer.
Sica S; Salutari P; Ciarli M; Piccirillo N; Laurenti L; Menichella G; Leone G
Leukemia; 1997 Nov; 11(11):1990-2. PubMed ID: 9369440
[No Abstract] [Full Text] [Related]
7. Therapy-related acute promyelocytic leukemia: a report on 16 cases.
Detourmignies L; Castaigne S; Stoppa AM; Harousseau JL; Sadoun A; Janvier M; Demory JL; Sanz M; Berger R; Bauters F
J Clin Oncol; 1992 Sep; 10(9):1430-5. PubMed ID: 1517786
[TBL] [Abstract][Full Text] [Related]
8. Secondary acute promyelocytic leukemia in a patient with non-Hodgkin's lymphoma treated with VP-16 and MST-16.
Okamoto T; Okada M; Wakae T; Mori A; Takatsuka H; Kakishita E
Int J Hematol; 2002 Jan; 75(1):107-8. PubMed ID: 11843282
[No Abstract] [Full Text] [Related]
9. [Leukemia in patients with breast carcinoma after adjuvant chemotherapy and/or postoperative radiotherapy].
Sack H
Strahlenther Onkol; 1995 Jul; 171(7):420-1. PubMed ID: 7631268
[No Abstract] [Full Text] [Related]
10. Acute promyelocytic leukaemia following radioiodine therapy.
Richards EM; Marcus RE
Clin Lab Haematol; 1993; 15(1):55-8. PubMed ID: 8472497
[No Abstract] [Full Text] [Related]
11. Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience.
Diamandidou E; Buzdar AU; Smith TL; Frye D; Witjaksono M; Hortobagyi GN
J Clin Oncol; 1996 Oct; 14(10):2722-30. PubMed ID: 8874333
[TBL] [Abstract][Full Text] [Related]
12. Therapy-related acute promyelocytic leukemia.
Pogliani EM; Bregani ER; Mangiagalli M; Corneo G
Leukemia; 1993 Oct; 7(10):1679. PubMed ID: 8412334
[No Abstract] [Full Text] [Related]
13. Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French Adjuvant Study Group 05 randomized trial.
French Adjuvant Study Group
J Clin Oncol; 2001 Feb; 19(3):602-11. PubMed ID: 11157009
[TBL] [Abstract][Full Text] [Related]
14. Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group.
Crump M; Tu D; Shepherd L; Levine M; Bramwell V; Pritchard K
J Clin Oncol; 2003 Aug; 21(16):3066-71. PubMed ID: 12915595
[TBL] [Abstract][Full Text] [Related]
15. Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: cyclophosphamide, epirubicin and fluorouracil compared with docetaxel + epirubicin and cyclophosphamide.
Andersen KG; Jensen MB; Kehlet H; Gärtner R; Eckhoff L; Kroman N
Acta Oncol; 2012 Nov; 51(8):1036-44. PubMed ID: 22676048
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of secondary leukemias.
Visani G; Pagano L; Pulsoni A; Tosi P; Piccaluga PP; Pastano R; Grafone T; Malagola M; Isidori A; Tura S
Leuk Lymphoma; 2000 May; 37(5-6):543-9. PubMed ID: 11042514
[TBL] [Abstract][Full Text] [Related]
17. Double recurrence of double cancers: Rhabdomyosarcoma and secondary AML.
Kajita N; Saito Y; Makimoto A; Miyahara S; Yuza Y
Pediatr Int; 2020 Jun; 62(6):742-744. PubMed ID: 32495974
[No Abstract] [Full Text] [Related]
18. Acute promyelocytic leukemia after treatment of malignant glioma in a patient with von Recklinghausen's disease: case report and review of the literature.
Wiernik PH; Muse IM
Leukemia; 1996 Jan; 10(1):178-82. PubMed ID: 8558926
[No Abstract] [Full Text] [Related]
19. Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group.
Campone M; Roché H; Kerbrat P; Bonneterre J; Romestaing P; Fargeot P; Namer M; Monnier A; Montcuquet P; Goudier MJ; Fumoleau P
Ann Oncol; 2005 Aug; 16(8):1343-51. PubMed ID: 15905306
[TBL] [Abstract][Full Text] [Related]
20. Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy.
Linassier C; Barin C; Calais G; Letortorec S; Brémond JL; Delain M; Petit A; Georget MT; Cartron G; Raban N; Benboubker L; Leloup R; Binet C; Lamagnère JP; Colombat P
Ann Oncol; 2000 Oct; 11(10):1289-94. PubMed ID: 11106118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
